At a glance
ClinicalIndex Comparison RecordN/ACompleted· 133 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 4
- ✓Adult age ≥18 years
- ✓Diagnosis of septic shock requiring vasopressor therapy (norepinephrine, epinephrine, phenylephrine, dopamine, or vasopressin)
- ✓Admitted to ICU at Rush University Medical Center
- ✓Admission between 01/01/2012 and 07/1/2016
Key exclusion· 4
- ✕Pregnant patients
- ✕Transfer from outside hospital already on vasopressors
- ✕Admitted in cardiopulmonary arrest
- ✕Prior cardiac arrest within 24 hours of admission to RUMC
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock
In Brief
An observational study for Septic Shock. Completed, enrolled 133 participants across 1 site.
Detailed Summary
Retrospective study to examine the effects of chronic antihypertensive medications on vasopressor dosing in septic shock
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSeptic Shock
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartAug 2016
First PostedAug 2016
Primary CompletionFeb 2017
Study CompletionMar 2017
TodayJul 2026
First PostedAug 30, 2016
Enrollment StartAug 1, 2016
Primary CompletionFeb 1, 2017
Study CompletionMar 31, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.8 years ago